Eva Schott

Senior Associate

Eva Schott is a senior associate on the Corporate and Commercial and Life Sciences and Health Law teams. She advises national and international companies as well as individuals on all aspects of corporate, pharmaceutical and real estate law. Eva Schott also deals with litigation matters across all these areas.

In advising on pharmaceutical issues, Eva Schott is also able to draw on her extensive experience serving as Legal Counsel at a major pharmaceutical company based in Basel.

Practice Areas:

Corporate and Commercial
Life Sciences and Health Law
Responsible Business Conduct / ESG


2015 Attorney at law at Wenger Plattner, Zurich
2013 Legal Counsel at Actelion Pharmaceuticals Ltd., Allschwil, Basel-Landschaft
2010 Attorney at law at Wenger Plattner, Basel
2007 University of Basel (MLaw)
2006 University of Fribourg (BLaw)

Selected publications:

Newsletter 1/21: Modernisation of Swiss Company Law
After a project lasting ten years, the extensive revision to company law is (finally) being implemented. The provisions relating to gender quotas and transparency rules for commodity companies (both with a transition period) already entered into force on 1 January 2021; the main part will enter into force in 2022. Key features of the new law are the introduction of new principles on corporate governance such as those relating to gender quotas and transparency regulations for commodity companies. The revision also includes a variety of simplified procedures and clarifications, in particular more flexibility for changes to share capital, the permissibility of interim dividends and purely virtual general meetings. Read our newsletter to find out what opportunities the revised law will offer, but also what duties will require action.

LexisNexis® M&A Law Guide 2019
The sixth annual complimentary guide to understanding M&A practices around the world with an Asia-Pacific focus

Praxisratgeber zur Planung und Strukturierung der Unternehmensnachfolge
Vertrags- und gesellschaftsrechtliche Umsetzung / Güter- und erbrechtliche Umsetzung / Steuerliche Umsetzung

LexisNexis Mergers & Acquisitions Law Guide 2018
Jurisdictional Q&A - Switzerland

Newsletter 1/17: Practical implementation of the new disclosure requirements for shareholders and LLC members
The new disclosure requirements for acquirers of shares and limited liability company (“LLC”) capital contributions have led to considerable uncertainty in practice. The purpose of these requirements is to enable information to be obtained on both the owners and beneficial owners of companies limited by shares or LLCs. There are harsh sanctions for failure to comply with disclosure obligations: membership rights will be suspended and property rights may lapse. In practice, many questions remain unanswered with regard to implementation. Some possible approaches are set out below.

LexisNexis Mergers & Acquisitions Law Guide 2017
Jurisdictional Q&A - Switzerland


Eva Schott MLaw
Attorney at Law
Wenger Plattner
Attorneys at Law Tax Advisors Public Notaries
Seestrasse 39 | P.O. Box
8700 Küsnacht-Zürich

T +41 43 222 38 00
F +41 43 222 38 01


Bar admission (2010)


German, English, French